
News|Articles|January 1, 2006
Pipeline Preview
Methylphenidate transdermal patch (Daytrana, Shire/Noven) to treat attention-deficit/hyperactivity disorder (ADHD)
Advertisement
Recommendations for approval
Approvable designations
Fast-track designation
Priority review
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
340B reform and drug shortages are among hospital pharmacy concerns, survey finds
2
Dual-target ADC shows promising PFS signal in mCRPC | ASCO 2025
3
Healthcare’s workforce has a scale problem, but new model is emerging
4
Daraxonrasib trial exceeds expectations after decades of disappointment in pancreatic cancer drug development
5


























